A carregar...

Phase II Clinical Study of BC-3781, a Pleuromutilin Antibiotic, in Treatment of Patients with Acute Bacterial Skin and Skin Structure Infections

This study investigated the potential of the novel systemic pleuromutilin antibiotic BC-3781 to treat patients with an acute bacterial skin and skin structure infection (ABSSSI) caused by a Gram-positive pathogen. Patients were randomized to intravenous BC-3781 100 mg, BC-3781 150 mg, or vancomycin...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Prince, W. T., Ivezic-Schoenfeld, Z., Lell, C., Tack, K. J., Novak, R., Obermayr, F., Talbot, G. H.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2013
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3632892/
https://ncbi.nlm.nih.gov/pubmed/23422913
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02106-12
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!